Status:
COMPLETED
Effect of Infusion of Lidocaine, Magnesium and Remifentanil Perioperatively in Patients Undergoing Mastectomy
Lead Sponsor:
Hospital de Base
Conditions:
Postoperative Pain
Eligibility:
FEMALE
18-75 years
Phase:
PHASE4
Brief Summary
This study aims to compare the quality of perioperative analgesia of lidocaine, magnesium sulphate and remifentanil in patients undergoing mastectomy
Detailed Description
The opioid analgesics are commonly used in clinical practice for pain management in the perioperative period. However, many side effects are associated with its use, such as respiratory depression, na...
Eligibility Criteria
Inclusion
- Female patients scheduled for elective surgery performed mastectomy;
- Physical Status P1 and P2 of the American Society of Anesthesiology (ASA);
Exclusion
- Patients with less than 18 years and above 75 years of age;
- Patients who are allergic to morphine and / or lidocaine and / or remifentanil and / or magnesium sulphate;
- Patients with chronic pain;
- Patients with severe hepatic disease;
- Patients with severe renal disease;
- Patients with neurological disorders;
- Patients included in other clinical currently or within the past three months under general anesthesia studies;
- Patients who refuse to participate in the study;
- Any other condition that in the opinion of the investigator, may pose a risk to the patient or interfere with the study objectives;
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02309879
Start Date
August 1 2014
End Date
July 1 2015
Last Update
August 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Base do Distrito Federal
Brasília, Federal District, Brazil, 70680250